AI Article Synopsis
- The text references a correction made to a previously published article, indicating that there may have been errors or necessary clarifications in the original paper.
- The DOI (Digital Object Identifier) provided is a unique identifier for the specific article, enabling easy access and citation.
- It signifies that the scientific community values accuracy and transparency in research publications.
Article Abstract
[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10797412 | PMC |
| http://dx.doi.org/10.3389/fimmu.2023.1346845 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546].
Eur J Surg Oncol
January 2025
Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China. Electronic address:
Corrigendum to "Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study": [ESMO Open 9 (2024) 10.1016/j.esmoop.2024.103665].
ESMO Open
November 2024
Scientific Direction, Candiolo Cancer Institute, FPO-IRCCS Candiolo, Turin, Italy.
Corrigendum to "Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives" [Crit. Rev. Oncol./Hematol. 181 (2023) 103900].
Crit Rev Oncol Hematol
August 2024
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine, University of Barcelona, Barcelona, Spain. Electronic address:
Corrigendum: Deep learning or radiomics based on CT for predicting the response of gastric cancer to neoadjuvant chemotherapy: a meta-analysis and systematic review.
Front Oncol
May 2024
Department of Gastroenterology, the First Hospital of Lanzhou University, Lanzhou, China.
[This corrects the article DOI: 10.3389/fonc.2024.
View Article and Find Full Text PDFCorrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812].
Ann Oncol
August 2024
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia; Department of Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!